ActRIIB


Also found in: Medical.
AcronymDefinition
ActRIIBActivin A Receptor, Type IIB
References in periodicals archive ?
an exclusive license in markets outside of North America for the ActRIIB
0 million made to Acceleron on entering the licence and collaboration agreement for development of the ActRIIB class of molecules.
0 million (1% of product sales) on entering the collaboration with Acceleron for development of the ActRIIB class of molecules.
Deal Grants Shire Exclusive Ex-North American Rights to Acceleron's Innovative Class of ActRIIB Molecules, Including ACE-031 Currently in Phase 2 Development to Treat Duchenne Muscular Dystrophy
498 Million Deal Grants Shire Exclusive Ex-North American Rights to Acceleron's Innovative Class of ActRIIB Molecules Including ACE-031, Currently in Phase 2 Trials to Treat Patients with Duchenne Muscular Dystrophy
ACE-031 and other ActRIIB molecules have the potential to be
ACE-031 is a completely human, recombinant fusion protein that is produced by joining a portion of the human ActRIIB receptor to a portion of a human antibody.